Subcutaneous treprostinil for pulmonary hypertension in chronic lung disease of infancy

Pediatrics

Volumn 134, Issue 1, 2014, Pages

  Ferdman, Dina J ^a   Rosenzweig, Erika B ^a   Zuckerman, Warren A ^a   Krishnan, Usha ^a  

^a College of Physicians and Surgeons ^*  (United States)

Author keywords

Chronic lung disease of infancy; Extreme prematurity; Pulmonary arterial hypertension; Treprostinil

Indexed keywords

BOSENTAN; ILOPROST; MILRINONE; NITRIC OXIDE; PROSTACYCLIN; SILDENAFIL; TREPROSTINIL;

ABSENCE OF SIDE EFFECTS; ARTICLE; CASE STUDY; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; CONTINUOUS INFUSION; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEALTH STATUS; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HUMAN; INFANT; MALE; OUTCOME ASSESSMENT; PREMATURITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SEPTIC SHOCK;

CHRONIC LUNG DISEASE OF INFANCY; EXTREME PREMATURITY; PULMONARY ARTERIAL HYPERTENSION; TREPROSTINIL;

ANTIHYPERTENSIVE AGENTS; CHRONIC DISEASE; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFANT; INFUSIONS, SUBCUTANEOUS; LUNG DISEASES; MALE;

EID: 84904210979     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2013-2330     Document Type: Article

References (18)

1. McLaughlin VV, Archer SL, Badesch DB, et al American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53(17):1573-1619
2. Mourani PM, Sontag MK, Ivy DD, Abman SH. Effects of long-term sildenafil treatment for pulmonary hypertension in infants with chronic lung disease. J Pediatr. 2009. 154 (3):379-384
3. Khemani E, McElhinney DB, Rhein L, et al. Pulmonary artery hypertension in formerly premature infants with bronchopulmonary dysplasia: clinical features and outcomes in the surfactant era. Pediatrics. 2007;120(6):1260-1269 (Pubitemid 350223677)
4. Krishnan U, Krishnan S, Gewitz M. Treatment of pulmonary hypertension in children with chronic lung disease with newer oral therapies. Pediatr Cardiol. 2008;29(6):1082-1086
5. Barst RJ, Galie N, Naeije R, et al. Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil. Eur Respir J. 2006;28(6):1195-1203 (Pubitemid 44883856)
6. Galiè N, Negro L, Simonneau G. The use of combination therapy in pulmonary arterial hypertension: new developments. Eur Respir Rev. 2009;18(113):148-153
7. Barst RJ, Maislin G, Fishman AP. Vasodilator therapy for primary pulmonary hypertension in children. Circulation. 1999;99(9):1197-1208
8. Sadushi-Koliçi R, Skoro-Sajer N, Zimmer D, et al. Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension. J Heart Lung Transplant. 2012;31(7):735-743
9. Rubenfire M, McLaughlin VV, Allen RP, et al. Transition from IV epoprostenol to subcutaneous treprostinil in pulmonary arterial hypertension: a controlled trial. Chest. 2007;132(3):757-763
10. Siehr SL, Ivy DD, Miller-Reed K, Ogawa M, Rosenthal DN, Feinstein JA. Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics. J Heart Lung Transplant. 2013;32 (5):546-552
11. Mathier MA, McDevitt S, Saggar R. Subcutaneous treprostinil in pulmonary arterial hypertension: practical considerations. J Heart Lung Transplant. 2010;29(11):1210-1217
12. Levy M, Celermajer DS, Bourges-Petit E, Del Cerro MJ, Bajolle F, Bonnet D. Add-on therapy with subcutaneous treprostinil for refractory pediatric pulmonary hypertension. J Pediatr. 2011;158(4):584-588
13. Porta NF, Steinhorn RH. Pulmonary vasodilator therapy in the NICU: inhaled nitric oxide, sildenafil, and other pulmonary vasodilating agents. Clin Perinatol. 2012;39 (1):149-164
14. Simons SH, Tibboel D. Pain perception development and maturation. Semin Fetal Neonatal Med. 2006;11(4):227-231 (Pubitemid 43794845)
15. Slater R, Cantarella A, Gallella S, et al. Cortical pain responses in human infants. J Neurosci. 2006;26(14):3662-3666
16. Johnston CC, Stevens BJ. Experience in a neonatal intensive care unit affects pain response. Pediatrics. 1996;98(5):925-930 (Pubitemid 26398777)
17. Anand KJS. Pain, plasticity, and premature birth: a prescription for permanent suffering? Nat Med. 2000;6(9):971-973
18. Seaton SE, King S, Manktelow BN, Draper ES, Field DJ. Babies born at the threshold of viability: changes in survival and workload over 20 years. Arch Dis Child Fetal Neonatal Ed. 2013;98(1):F15-F20